002022.SZ Stock Analysis
00
Attractive
Based on Eyestock quantitative analysis, 002022.SZ`s fundamental data and valuation indicate an investment grade of Attractive at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
High score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly undervalued
Shanghai Kehua Bio-Engineering Co., Ltd. engages in the research, development, manufacture, and marketing business operation covering the whole industrial chain of vitro diagnostic device (IVD). The company is headquartered in Shanghai, Shanghai and currently employs 1,485 full-time employees. The company went IPO on 2004-07-21. The firm's products include in vitro diagnostic reagents, medical instruments and vacuum blood drawing supplies, among others. The firm operates its businesses in both domestic and overseas markets, with China as its main market.